Cargando…
Role of Beta Cell Function and Insulin Resistance in the Development of Gestational Diabetes Mellitus
Background: Gestational diabetes mellitus (GDM) is a pregnancy complication characterized by second trimester hyperglycemia. Untreated, GDM is related to an increased risk for adverse pregnancy outcomes. Both beta cell dysfunction and insulin resistance underlie impaired glucose tolerance. Understan...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9231208/ https://www.ncbi.nlm.nih.gov/pubmed/35745174 http://dx.doi.org/10.3390/nu14122444 |
_version_ | 1784735275720638464 |
---|---|
author | Ellerbrock, Jonas Spaanderman, Benthe van Drongelen, Joris Mulder, Eva Lopes van Balen, Veronica Schiffer, Veronique Jorissen, Laura Alers, Robert-Jan Leenen, Jeanine Ghossein-Doha, Chahinda Spaanderman, Marc |
author_facet | Ellerbrock, Jonas Spaanderman, Benthe van Drongelen, Joris Mulder, Eva Lopes van Balen, Veronica Schiffer, Veronique Jorissen, Laura Alers, Robert-Jan Leenen, Jeanine Ghossein-Doha, Chahinda Spaanderman, Marc |
author_sort | Ellerbrock, Jonas |
collection | PubMed |
description | Background: Gestational diabetes mellitus (GDM) is a pregnancy complication characterized by second trimester hyperglycemia. Untreated, GDM is related to an increased risk for adverse pregnancy outcomes. Both beta cell dysfunction and insulin resistance underlie impaired glucose tolerance. Understanding the dominant mechanism predisposing to GDM may be important to provide effective treatment in order to improve perinatal outcomes. We hypothesize that insulin resistance rather that beta cell dysfunction predisposes to GDM. Methods: A 75g oral glucose tolerance test (OGTT) was performed on 2112 second-trimester pregnant women to determine the relationship between insulin resistance (HOMA-IR), beta cell function (HOMA-β), and the prevalence of abnormal glucose handling. Results: High insulin resistance raised the risk of GDM (relative risk (RR) 6.1, 95% confidence interval (CI) (4.4–8.5)), as did beta cell dysfunction (RR 3.8, 95% CI (2.7–5.4)). High insulin resistance, but not beta cell function, enhances the necessity for additional glucose lowering medication on top of a low carbohydrate diet in women diagnosed with GDM. Conclusions: Both high insulin resistance and beta cell dysfunction increase the risk of GDM. As increased insulin resistance, rather than beta cell function, is related to an insufficient response to a low carbohydrate diet, we speculate that insulin sensitizers rather than insulin therapy may be the most targeted therapeutic modality in diet-insensitive GDM. |
format | Online Article Text |
id | pubmed-9231208 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-92312082022-06-25 Role of Beta Cell Function and Insulin Resistance in the Development of Gestational Diabetes Mellitus Ellerbrock, Jonas Spaanderman, Benthe van Drongelen, Joris Mulder, Eva Lopes van Balen, Veronica Schiffer, Veronique Jorissen, Laura Alers, Robert-Jan Leenen, Jeanine Ghossein-Doha, Chahinda Spaanderman, Marc Nutrients Article Background: Gestational diabetes mellitus (GDM) is a pregnancy complication characterized by second trimester hyperglycemia. Untreated, GDM is related to an increased risk for adverse pregnancy outcomes. Both beta cell dysfunction and insulin resistance underlie impaired glucose tolerance. Understanding the dominant mechanism predisposing to GDM may be important to provide effective treatment in order to improve perinatal outcomes. We hypothesize that insulin resistance rather that beta cell dysfunction predisposes to GDM. Methods: A 75g oral glucose tolerance test (OGTT) was performed on 2112 second-trimester pregnant women to determine the relationship between insulin resistance (HOMA-IR), beta cell function (HOMA-β), and the prevalence of abnormal glucose handling. Results: High insulin resistance raised the risk of GDM (relative risk (RR) 6.1, 95% confidence interval (CI) (4.4–8.5)), as did beta cell dysfunction (RR 3.8, 95% CI (2.7–5.4)). High insulin resistance, but not beta cell function, enhances the necessity for additional glucose lowering medication on top of a low carbohydrate diet in women diagnosed with GDM. Conclusions: Both high insulin resistance and beta cell dysfunction increase the risk of GDM. As increased insulin resistance, rather than beta cell function, is related to an insufficient response to a low carbohydrate diet, we speculate that insulin sensitizers rather than insulin therapy may be the most targeted therapeutic modality in diet-insensitive GDM. MDPI 2022-06-13 /pmc/articles/PMC9231208/ /pubmed/35745174 http://dx.doi.org/10.3390/nu14122444 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Ellerbrock, Jonas Spaanderman, Benthe van Drongelen, Joris Mulder, Eva Lopes van Balen, Veronica Schiffer, Veronique Jorissen, Laura Alers, Robert-Jan Leenen, Jeanine Ghossein-Doha, Chahinda Spaanderman, Marc Role of Beta Cell Function and Insulin Resistance in the Development of Gestational Diabetes Mellitus |
title | Role of Beta Cell Function and Insulin Resistance in the Development of Gestational Diabetes Mellitus |
title_full | Role of Beta Cell Function and Insulin Resistance in the Development of Gestational Diabetes Mellitus |
title_fullStr | Role of Beta Cell Function and Insulin Resistance in the Development of Gestational Diabetes Mellitus |
title_full_unstemmed | Role of Beta Cell Function and Insulin Resistance in the Development of Gestational Diabetes Mellitus |
title_short | Role of Beta Cell Function and Insulin Resistance in the Development of Gestational Diabetes Mellitus |
title_sort | role of beta cell function and insulin resistance in the development of gestational diabetes mellitus |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9231208/ https://www.ncbi.nlm.nih.gov/pubmed/35745174 http://dx.doi.org/10.3390/nu14122444 |
work_keys_str_mv | AT ellerbrockjonas roleofbetacellfunctionandinsulinresistanceinthedevelopmentofgestationaldiabetesmellitus AT spaandermanbenthe roleofbetacellfunctionandinsulinresistanceinthedevelopmentofgestationaldiabetesmellitus AT vandrongelenjoris roleofbetacellfunctionandinsulinresistanceinthedevelopmentofgestationaldiabetesmellitus AT muldereva roleofbetacellfunctionandinsulinresistanceinthedevelopmentofgestationaldiabetesmellitus AT lopesvanbalenveronica roleofbetacellfunctionandinsulinresistanceinthedevelopmentofgestationaldiabetesmellitus AT schifferveronique roleofbetacellfunctionandinsulinresistanceinthedevelopmentofgestationaldiabetesmellitus AT jorissenlaura roleofbetacellfunctionandinsulinresistanceinthedevelopmentofgestationaldiabetesmellitus AT alersrobertjan roleofbetacellfunctionandinsulinresistanceinthedevelopmentofgestationaldiabetesmellitus AT leenenjeanine roleofbetacellfunctionandinsulinresistanceinthedevelopmentofgestationaldiabetesmellitus AT ghosseindohachahinda roleofbetacellfunctionandinsulinresistanceinthedevelopmentofgestationaldiabetesmellitus AT spaandermanmarc roleofbetacellfunctionandinsulinresistanceinthedevelopmentofgestationaldiabetesmellitus |